June09 House of Delegates report

June 12, 2009
Royal York, Toronto, Canada

Overview of the House of Delegates meeting:

PET Center of Excellence - Educational workshop at chapter meetings
EFR general fund from donations from leadership
Definition of molecular imaging- visualization, characterization, and measurement of biological processes at the molecular and cellular levels in humans and other living systems
Technologist training must include SPECT/PET CT in all programs by 2010-cirruculum approved
Technologist leadership is trying to attend chapters across the US
$150 million for new reactor for Mo99 in the US – with discussion of where Mo99 comes from now
Commission on Healthcare Policy-new healthcare reform will need criteria for procedures, may look at imaging separately
FDA does not agree with USP 797
SNM Clinical Trials Network- overview IND (investigational new drugs) for imaging biomarkers at specific centers- being done jointly with SNM, RSNA, and FDA
Strategic Plan Review Task Force is in place to develop a system to evaluate the progress of SNM strategic plan on an annual basis, establish a process to provide reports to BOD regarding the strategic plans effectiveness and vision using a dashboard format, Deborah Havens is a part of this task force The top five issues are as follows:

What proactive strategies should SNM be developing to navigate the Society through the current challenging times?
How can the Society refine and prioritize its relationship with and outreach with the following organizations to further SNM’s strategic discretion? (SNM, BOD, MICOE, TET COE, SRNA, AMI, ASTRO, NCON, ACC, ASNC, NIH, NCI, NHLBI, NIMH, NIDA, NIBB, NIGMS, NCRR)
Are the current mission, values, and goal in the SNM’s strategic plan still relevant and valid?
How can SNM’s continue to position itself as the leading molecular imaging society?
What is SNM’s role in providing certification for reading CT?

Respectfully submitted,

Deborah Havens, CNMT and Mike Middleton, MD